What Is Treximet?
Treximet is GlaxoSmithKline’s migraine medication, which has the generic name Sumatriptan/Naproxen Sodium and Sumatriptan. This drug is a nonsteroidal anti-inflammatory drug. Setotonin-1B and serotonin-1D receptor agonist. Sumatriptan is a headache medication, which narrows blood vessels around the brain. It also decrease the amount of substances that are in the body that can trigger some migraine symptoms. Naproxen reduces hormones that can cause inflammation and pain throughput the body. It is said that Treximet will only work when it is taken after headache has begun. In other words, it does not no prevent any headaches or reduce the frequency of getting them in the future. The commercial describes this drug as superior to Imitrex tablets
…show more content…
when it comes to relieving migraine pains because it works in two different ways. Those two ways were that it targets the nerves and blood vessels that triggers a migraine and it relieves inflammation that causes migraine pain. The drug Treximet is for women only.
In the television commercial three different are holding their head in their hands.
When the commercial starts playing it only shows face of the lady, so it is not possible to that it is not on her shoulders. The first thing she say is, “when I get a migraine, forget it, its excruciating.” After she makes her statement the screen zooms out and it finally shows the whole picture. The women shown in this advertisement are doing everyday activities, which makes it easier for women to relate to the activities shown includes picking the children up from the bus stop, grocery shopping, walking to work. After the women take the drug it shows one lady having a great day at work being productive, the second lady is with her husband cooking dinner with her husband while smiling and dancing around, and the last lady is teaching her son how to ride a bike. The commercial presents that after taking the drug life will be so much happier. The people who paid for the ad could have had the motivation to use these activities that many women encounter in everyday life, so it would give women the chance to relate to them. In the commercial, Treximet is superior Imitrex was repeated multiple times, which made it seem as if they were trying to prove a
point.
This study’s objective was to measure the cognitive effects of acute migraine and the following impact of acute treatment in a controlled setting. The study population consisted of thirty patients who met a specific criteria. The thirty patients were screened and randomly picked to take either Treximet or placebo in a 1:1 manner for the treatment of two migraines. This study was double-blind, and placebo-controlled. The results of this was that twenty five out of the thirty patients completed the study. There were no serious side effects from either of the Treximet or placebo. At the onset of the migraines there was a statistically significant side decline in the overall cognitive efficiency when it was compared to the migraine-free testing. For every subject in the testing. When the subjects who took Treximet were compared to the ones taking the placebo there was a statistically significant return to cognitive efficiency by measures of immediate and sustained attention, visual-spatial awareness, mental flexibility, and reaction time between one and two hours. No statistically significance for either of the groups in measures of complex reasoning or fine motor coordination. But there was a correlation between migraine severity and performance in the Treximet group only. The finding of this study was that there was a significant decline in global cognitive efficiency at the beginning of the attack from a migraine. But once Treximet was taken there was a faster recovery time in some measure of cognitive efficiency compared to the placebo group.
when it comes to relieving migraine pains because it works in two different ways. Those two ways were that it targets the nerves and blood vessels that triggers a migraine and it relieves inflammation that causes migraine pain. The drug Treximet is for women only.
In the television commercial three different are holding their head in their hands.
When the commercial starts playing it only shows face of the lady, so it is not possible to that it is not on her shoulders. The first thing she say is, “when I get a migraine, forget it, its excruciating.” After she makes her statement the screen zooms out and it finally shows the whole picture. The women shown in this advertisement are doing everyday activities, which makes it easier for women to relate to the activities shown includes picking the children up from the bus stop, grocery shopping, walking to work. After the women take the drug it shows one lady having a great day at work being productive, the second lady is with her husband cooking dinner with her husband while smiling and dancing around, and the last lady is teaching her son how to ride a bike. The commercial presents that after taking the drug life will be so much happier. The people who paid for the ad could have had the motivation to use these activities that many women encounter in everyday life, so it would give women the chance to relate to them. In the commercial, Treximet is superior Imitrex was repeated multiple times, which made it seem as if they were trying to prove a
point.
This study’s objective was to measure the cognitive effects of acute migraine and the following impact of acute treatment in a controlled setting. The study population consisted of thirty patients who met a specific criteria. The thirty patients were screened and randomly picked to take either Treximet or placebo in a 1:1 manner for the treatment of two migraines. This study was double-blind, and placebo-controlled. The results of this was that twenty five out of the thirty patients completed the study. There were no serious side effects from either of the Treximet or placebo. At the onset of the migraines there was a statistically significant side decline in the overall cognitive efficiency when it was compared to the migraine-free testing. For every subject in the testing. When the subjects who took Treximet were compared to the ones taking the placebo there was a statistically significant return to cognitive efficiency by measures of immediate and sustained attention, visual-spatial awareness, mental flexibility, and reaction time between one and two hours. No statistically significance for either of the groups in measures of complex reasoning or fine motor coordination. But there was a correlation between migraine severity and performance in the Treximet group only. The finding of this study was that there was a significant decline in global cognitive efficiency at the beginning of the attack from a migraine. But once Treximet was taken there was a faster recovery time in some measure of cognitive efficiency compared to the placebo group.